Entries tagged "contingent value right"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "contingent value right."

3 result(s) displayed (1 - 3 of 3)

EC quashes Allos drug payout

The decision tied to the approval of Folotyn cannot be appealed, but rejection does not endanger the company's $200 million merger with Spectrum Pharmaceuticals. Continue reading

Posted on June 28, 2012 4:19 PM

Mitigating risk in a growing M&A market

What can boards of directors and deal counsel do to reduce the likelihood that a proposed merger will result in litigation? Continue reading

Posted on June 12, 2012 3:03 PM

Genzyme board member Ralph Whitworth on Sanofi offer

The Deal Economy 2011: Even with a structure that includes a contingent rights value, the $69 per share offer from French pharmaceutical firm Sanofi-Aventis is still too low, Whitworth said. Continue reading

Posted on January 13, 2011 10:21 AM

Movable Type search results powered by Fast Search